title: In patients with type 2 diabetes and CVD, empagliflozin reduced incident or worsening nephropathy at 3.1 y.
authors.affiliation: Icahn School of Medicine at Mount Sinai St. Luke's and Mount Sinai West HospitalNew York, New York, USA.
authors.forename: Tejas
authors.initials: T
authors.lastname: Patel
mesh_terms: D001559:Benzhydryl Compounds; D003924:Diabetes Mellitus, Type 2; D005960:Glucosides; D006801:Humans; D007004:Hypoglycemic Agents
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents; C570240:empagliflozin